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ABSTRACT
National surveillance of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA)
isolates by pulsed-field gel electrophoresis (PFGE) typing allowed identification of rarely occurring
‘sporadic’ isolates with patterns significantly distinct from those of major epidemic clones of methicillin-
resistant S. aureus (MRSA) circulating in Belgian hospitals. The aim of the present study was to compare
the genetic background, antibiotic susceptibility profile and in vitro growth rates of 36 MRSA isolates
with either ‘epidemic’ or ‘sporadic’ PFGE profiles to identify factors that could be involved in the
epidemic behaviour of S. aureus. Sequence analysis of seven housekeeping genes (multilocus sequence
typing) and seven surface-associated genes, combined with staphylococcal cassette chromosome mec
(SCCmec) typing and spa typing results, segregated sporadic isolates into four groups: (1) isolates
phylogenetically distant from epidemic HA-MRSA clones that possessed several properties of
community-acquired MRSA strains; (2) isolates derived from the same methicillin-susceptible S. aureus
ancestor as epidemic isolates but possessing a distinct type of SCCmec; and (3) and (4) isolates that were
closely related to epidemic strains, either as recent descendants of these or as intermediate evolutionary
steps between epidemic HA-MRSA strains and their putative ancestors. Sporadic isolates did not show
slower growth in vitro than epidemic isolates. These findings suggest that the SCCmec type and
insertion ⁄ deletion of other mobile genetic elements may be involved in modulating the epidemic
behaviour of MRSA strains of similar genetic background, independently of fitness cost.
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INTRODUCTION
Staphylococcus aureus strains resistant to methicillin
and other b-lactams (MRSA) emerged in 1961,
shortly after the introduction of methicillin into
clinical practice [1]. MRSA infection has become a
major health threat, causing worldwide outbreaks
in the hospital setting (hospital-acquired (HA)-
MRSA) as well as in the community (community-
acquired (CA)-MRSA). Diverse typing methods
used by international surveillance networks,
including pulsed-field gel electrophoresis (PFGE)
of genomic macrorestriction fragments, established
that the large majority of MRSA isolates belong to a
limited set of epidemic clones worldwide [2]. More
recently, the combination of multilocus sequence
typing (MLST) and staphylococcal cassette chro-
mosome mec (SCCmec) typing applied to a large
international S. aureus strain collection revealed
that these epidemic MRSA clones emerged upon
repeated acquisition (at least 20 times) of SCCmec
by successful methicillin-susceptible S. aureus
(MSSA) clones belonging to five phylogenetically
distinct lineages or clonal complexes (CCs): CC8,
CC5, CC45, CC22 and CC30 [3].
Beside these pandemic MRSA clones, other
clones seem to be ‘restricted’ to a peculiar geo-
graphical area (‘minor’ clones) or have been
recovered from a single patient or a few patients
(‘sporadic’ clones) [4]. Little is known about these
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clones and why they appear to be less able to
spread. The few studies performed on the phylo-
genetic background of these ‘less frequent’ MRSA
clones failed to identify any association between
epidemic behaviour and particular lineages [5,6].
The Belgian National Reference Laboratory for
Staphylococci has conducted national epidemio-
logical surveillance of MRSA isolates from hospi-
talised patients in Belgium since 1992 [7]. As in
other countries, molecular typing data show that
nearly 90% of Belgian isolates collected since then
belong to nine predominant PFGE types, corre-
sponding to well-known international MRSA
clones [8–10]. The multidrug-resistant PFGE A1-
ST247-MRSA-I ‘Iberian’ clone was predominant
in Belgian hospitals during the early 1990s, and
was then progressively replaced by two ‘novel’
epidemic clones, which showed more limited
resistance to non-b-lactam antibiotics (the PFGE
B2-ST45-MRSA-IV ‘Berlin’ clone and the PFGE
A20-ST8-MRSA-IV ‘UK-EMRSA 2 ⁄ 6’ clone) [10].
In addition to these two clones, other epidemic
clones (A21-ST8-MRSA-IV, C3-ST5-MRSA-IV
‘Pediatric’ clone, L1-ST22-MRSA-IV ‘UK-EMRSA
15’ clone, G10 and C1-ST5-MRSA-II ‘New-York ⁄ -
Japan’ clone, and D8 ST228-MRSA-I ‘Southern
Germany’ clone) also appeared in Belgian hospi-
tals during the late 1990s, but remain more
scattered [9]. Over a decade of national surveil-
lance with PFGE typing, a few ‘sporadic’ strains
with peculiar patterns that set them apart from
epidemic strains were also identified.
These major changes in MRSA clone distribu-
tion in Belgium, as in other parts of the world,
raise the issue of why some MRSA clones were
able to supplant a well-established pandemic
clone while others were unable to spread. The
aim of the present study was to compare the
genetic background, methicillin resistance cas-
sette type, antibiotic susceptibility and in vitro
growth rate of MRSA isolates of ‘major epidemic’
and ‘sporadic’ PFGE types to identify phyloge-
netic and phenotypic factors that could be
involved in the epidemic behaviour of MRSA.
MATERIALS AND METHODS
Selection of bacterial isolates
Representative isolates of the nine most frequent Belgian
epidemic clones (n = 20) and sporadic isolates (n = 20) were
selected from the Belgian National Reference Laboratory for
Staphylococci collection of MRSA isolates. These non-dupli-
cated MRSA strains (n  1500) were collected from any
body site of consecutive patients hospitalised in acute-care
hospitals during national surveillance programmes in 1992,
1995, 1997, 2001 and 2003 [7–10]. The selection was based on
the PFGE profiles after SmaI macrorestriction. Restriction
fragments in the size range between 36 and 700 kb were
analysed by Dice similarity coefficient with a position
tolerance set at 0.8% using BioNumerics software version 4.0
(Applied Maths, Ghent, Belgium). A dendrogram of simi-
larity was built using the unweighted pair-group method
using arithmetic averages (UPGMA). Patterns differing by
fewer than seven fragments (>80% of similarity) were
considered to belong to the same group (represented by a
capital letter), and those differing by 0–3 fragments to the
same type (represented by a number) [10]. A PFGE type was
considered to be epidemic if present in at least two
hospitals, and major epidemic PFGE types (n = 9) are types
identified in at least 10% of isolates from at least one of the
five surveillance programmes. A PFGE type was considered
to be sporadic if it presented a pattern with less than 80%
similarity (which corresponds to a difference of more than
six DNA fragments [7,11]) with any other PFGE pattern in
the concatenated dendrogram of five national MRSA sur-
veillance programmes. Multiple isolates recovered over time
within each major epidemic type were selected to cover the
11-year surveillance period.
All isolates were confirmed by PCR for 16S rRNA, and nuc
and mecA genes by PCR as previously described [12].
Molecular typing methods
The genomic DNA of the 20 isolates with sporadic PFGE types
in the general database (see ‘Selection of bacterial isolates’) was
extracted again, digested and re-analyzed on a single electro-
phoresis gel in a CHEF-Mapper system (Bio-Rad Laboratories,
Nazareth, Belgium) as previously described [7]. The patterns
of these strains were than re-clustered, together with the 20
selected epidemic patterns, by UPGMA clustering (same
settings as described above). The similarity of macrorestriction
patterns was determined both by visual comparison and by
computer matching. Four of the 20 ‘sporadic’ isolates initially
selected were excluded according to this analysis: one isolate
presented a pattern similar (<4-band difference) to that of one
epidemic strain, PFGE B2 (presumably due to a misclassifica-
tion error in the database); three other isolates from different
annual surveys clustered together (four-band difference) in the
same group. Following this verification step, 16 confirmed
unrelated sporadic isolates were included for further analysis.
The 20 representative ‘epidemic’ isolates clustered as expected
into nine distinct PFGE types.
spa typing was performed as described by Mellmann et al.
[13]. spa types were determined with the Ridom StaphType
software version 1.3 (Ridom GmbH, Wu¨rzburg, Germany) and
analyzed by the BURP algorithm with the default parameters.
These assume that spa types shorter than five repeats are non-
typeable and that spa types belong to the same group if the cost
is less than or equal to 4 (excision, duplications, substitution
and indels model) [14].
agr type was determined by multiplex PCR as described by
Gilot et al. [15].
MLST was performed as described by Enright et al. [16] on
500-bp fragments of seven housekeeping (hk) genes. The
sequence types were determined with the MLST database
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(http://www.mlst.net). Additionally, sequences of 450-bp
fragments of seven surface protein genes (sasA, sasB, sasD,
sasE, sasF, sasH and sasI) were determined as described by
Robinson et al. [17]. Alleles were assigned by alignment with
the sas gene sequences deposited in GeneBank (AY175407–
AY175464 [17] and AY442690–AY442811 [18]).
SCCmec typing was performed by multiplex PCR as
described by Oliveira et al. [19].
Phylogenetic analysis
Sequences were aligned and maximum-parsimony (MP) trees
were built with BioNumerics 4.0 (Applied Maths) using the
absolute number of nucleotide differences between sequence
types (STs).
Susceptibility testing
Susceptibility to 16 antimicrobial agents (penicillin, erythro-
mycin, clindamycin, quinupristin–dalfopristin, tetracycline,
fusidic acid, gentamicin, tobramycin, kanamycin, linezolid,
mupirocin, rifampin, ciprofloxacin, cefoxitin, chloramphenicol
and trimethoprim–sulfamethoxazole) was determined by the
disk-diffusion method (Rosco Neosensitabs, Taastrup, Den-
mark) according to CLSI criteria [20]. For fusidic acid, CA-SFM
interpretation criteria were used [21], and for mupirocin,
BSAC interpretation criteria [22] were used. Vancomycin
susceptibility was tested on vancomycin screen agar according
to CLSI recommendations: a McFarland 0.5 inoculum spotted
onto brain–heart infusion (BHI) agar supplemented with
6 mg ⁄ L vancomycin (Becton Dickinson, Heidelberg, Germany)
and incubated for a full 24 h at 35C.
Toxin and resistance gene detection
The presence of exfoliatin A, exfoliatin B, Panton–Valentine
leukocidin (PVL) (lukS–lukF PV) and toxic shock syndrome
toxin 1 (TSST-1) genes was tested by PCR as described by Lina
et al. [23].
Tests for the aminoglycoside-modifying enzymes encoded
by aac(6¢)-aph(2¢), ant(4¢), and aph(3¢), the ribosomal methylases
encoded by ermA and ermC, the macrolide efflux pumps
encoded by msrA and msrB, the streptogramin A-inactivating
enzyme encoded by vatB, the genes encoding the tetracycline
efflux pump system (tetK) and the ribosomal protection
protein (tetM) were analyzed by PCR as described by Denis
et al. [9,24].
Growth rates
Each strain tested was cultured on Columbia agar with 5%
sheep blood (bioMe´rieux) at 35C for 24 h, and then resus-
pended in T2 buffer (70 mM NaCl, 30 mM K2SO4, 10 mM
KH2PO4, 20 mM Na2HPO4, 1 mM MgSO4, 1 mM CaCl2 and
0.001% gelatin); the density was then adjusted to a 1
MacFarland standard. One hundred microlitres of this sus-
pension was then suspended in 5 mL of BHI agar and
incubated at 35C with agitation. One hundred microlitre
aliquots were collected at t = 0 and every hour over a period of
8 h. Successive dilutions of each aliquot were then plated on
Columbia agar with 5% sheep blood by the Autoplate 4000
(Spiral Biotech, Norwood, MA, USA). The colony count was
carried out after 18 h of incubation at 35C with the Q-count
automated colony-counter (Spiral Biotech). The maximum
growth rate was calculated using the average of two non-linear
regressions (DataFit software, Oakdale Engineering) per-
formed on duplicate cultures of the same isolate, using the
formula X = Xoe
lt, where X is the biomass at t, X0 is the
biomass at t = 0, and l is the growth rate (h)1). For each
isolate, doubling time (T2) was then calculated from the
formula: T2 = ln2 ⁄l [25].
Statistical analysis
Statistical analysis was performed with Excel Analyze-it
software (Microsoft). After checking for normality by the
Kolmogorov–Smirnov normality test, t-tests were performed
with Welch’s approximation for unequal variances if neces-
sary.
RESULTS
spa types distribution
Twenty-three spa types were identified, 13 among
the 16 confirmed sporadic isolates and 14 among
the 20 epidemic isolates. Five spa types (t002, t008,
t032, t041 and t052) were found among both
epidemic and sporadic isolates (Table 1). Two spa
types were found with multiple sporadic and ⁄ or
epidemic isolates: the three PFGE A20 isolates,
one A21 isolate and two sporadic isolates were
t008, and three sporadic isolates were t001.
The BURP algorithm distributed all but one
isolate (t769, three repeats long, was excluded)
into three groups (spa-CCs) and three singletons
(groups represented by a single type). All but two
sporadic isolates (t019 and t355) clustered into the
same three spa groups as epidemic isolates: nine
in spa-CC008, five in spa-CC001 and one in
spa-CC740.
Genetic background of sporadic isolates
MLST clustered sporadic isolates into 11 STs and
epidemic isolates into seven STs (Table 1). Only
four out of the 14 STs found (ST8, ST247, ST5
and ST228) were common to sporadic and
epidemic isolates, accounting for 53% and 80%
of them, respectively. The BURST algorithm
clustered 87% (14 ⁄ 16) of sporadic isolates into
the same four CCs as 90% of epidemic isolates,
as confirmed by the MP tree (Fig. 1a). The two
sporadic isolates that were classified as spa type
singletons by the BURP algorithm were con-
firmed as phylogenetically very distant by MLST
(ST30 and ST377, respectively (Fig. 1a)).
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SCCmec elements associated with sporadic
isolates
The majority of sporadic isolates harboured
SCCmec types I or IV (six isolates each). Three of
these 12 isolates (one SCCmec type I and two
SCCmec type IV) harboured the fragment corre-
sponding to the integrated plasmid pUB110 [19]
and were thus classified as SCCmec type
variants IA and IVA, respectively. Two isolates
contained SCCmec type III, one contained SCCmec
type II, and one was non-typeable by the Oliveira
et al. multiplex PCR and was revealed to be
SCCmec type V (Ito et al. [26]). When SCCmec
type was combined with MLST sequence typing,
13 distinct clonal types were found among the 16
sporadic isolates (as compared to eight among 20
epidemic isolates). Four clonal types were shared
by sporadic and epidemic isolates: ST247-MRSA-I
(PFGE A1 and two sporadic isolates), ST8-
MRSA-IV (PFGE A20, A21 and two sporadic
isolates) ST5-MRSA-IV (PFGE C3 and one
sporadic isolate) and ST228-MRSA-I (PFGE D8
and two sporadic isolates).
Evolutionary relatedness between sporadic and
epidemic isolates
To further investigate the evolutionary related-
ness between the epidemic and sporadic isolates,
we performed MLST on seven additional genes
encoding S. aureus surface proteins (sas genes)
[17]. Fourteen sas profiles were found (Table 1).
Six sporadic and four epidemic isolates showed a
unique profile, while the remaining four profiles
were shared by isolates belonging to several
epidemic clones and sporadic isolates. When MP
trees based on sas genes and on hk genes were
compared, all the isolates were classified, accord-
ing to both trees, into similar groups or CCs,
although the distances and the branching order
between CCs were different (Fig. 1). The ST377
and the ST30 sporadic isolates were confirmed to
be distant from isolates belonging to the other
(a) (b)
Fig. 1. Maximum-parsimony (MP) tree of major epidemic and sporadic methicillin-resistant Staphylococcus aureus (MRSA)
isolates (n = 36) based on the concatenated sequences of the seven fragments of housekeeping genes used for multilocus
sequence typing (a) and the sequences of the seven fragments of sas genes (b). The absolute number of nucleotide
differences between sequence types (STs) are indicated above the branches, and the bootstrap values are indicated below.
STs represented only by epidemic isolates are in open circles; STs represented only by sporadic isolates are in closed circles;
and STs represented by both epidemic and sporadic isolates are in shaded circles. Dotted line circles delineate the five
major MRSA clonal complexes (CCs).
Hallin et al. Genetic background of sporadic MRSA 663
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 659–669
(a)
(b
)
F
ig
.
2
.
E
v
o
lu
ti
o
n
ar
y
p
at
te
rn
s
p
ro
p
o
se
d
w
it
h
in
cl
o
n
al
co
m
p
le
x
(C
C
)5
(a
)
an
d
C
C
8
(b
).
T
h
es
e
w
er
e
co
n
st
ru
ct
ed
b
y
th
e
ad
d
it
io
n
o
f
S
C
C
m
ec
ty
p
e
an
d
sp
a
ty
p
e
to
m
ax
im
u
m
-
p
ar
si
m
o
n
y
tr
ee
s
b
as
ed
o
n
th
e
co
n
ca
te
n
at
ed
se
q
u
en
ce
s
o
f
th
e
14
fr
ag
m
en
ts
o
f
h
o
u
se
k
ee
p
in
g
g
en
es
an
d
sa
s
g
en
es
,
b
y
as
su
m
in
g
th
e
fe
w
es
t
ch
an
g
es
to
th
e
tr
ee
s.
L
ar
g
e
ci
rc
le
s
re
p
re
se
n
t
th
e
p
u
ta
ti
v
e
an
ce
st
o
r.
In
ea
ch
ci
rc
le
,
th
e
co
m
p
le
te
g
en
o
ty
p
e
o
f
th
e
st
ra
in
is
sh
o
w
n
as
fo
ll
o
w
s:
th
e
p
u
ls
ed
-fi
el
d
g
el
el
ec
tr
o
p
h
o
re
si
s
ty
p
e,
th
e
m
u
lt
il
o
cu
s
se
q
u
en
ce
ty
p
in
g
(M
L
S
T
)
se
q
u
en
ce
ty
p
e,
th
e
S
C
C
m
ec
ty
p
e,
th
e
M
L
S
T
p
ro
fi
le
,
th
e
sa
s
g
en
e
p
ro
fi
le
an
d
th
e
sp
a
ty
p
e.
A
rr
o
w
s
in
d
ic
at
e
th
e
ch
an
g
es
b
et
w
ee
n
st
ra
in
s,
an
d
d
o
tt
ed
ar
ro
w
s
in
d
ic
at
e
an
al
te
rn
at
iv
e
ev
o
lu
ti
o
n
ar
y
h
y
p
o
th
es
is
.
E
p
id
em
ic
is
o
la
te
s
ar
e
in
o
p
en
ci
rc
le
s;
sp
o
ra
d
ic
is
o
la
te
s
ar
e
in
sh
ad
ed
ci
rc
le
s.
C
lo
se
d
ci
rc
le
s
re
p
re
se
n
t
ev
o
lu
ti
o
n
ar
y
st
ep
s
n
o
t
in
cl
u
d
ed
in
th
is
is
o
la
te
sa
m
p
le
.
p
U
B
11
0
in
d
ic
at
es
th
e
lo
ss
o
r
g
ai
n
o
f
p
la
sm
id
p
U
B
11
0
in
si
d
e
th
e
S
C
C
m
ec
el
em
en
t.
664 Clinical Microbiology and Infection, Volume 14 Number 7, July 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 659–669
CCs. All isolates belonging to CC45 (four PFGE
B2-ST45 isolates and one sporadic ST887 isolate)
showed exactly the same sas allelic profile. Sim-
ilarly, the majority of isolates (11 ⁄ 14) within CC8,
including both sporadic and PFGE A20, A21 and
A1 epidemic isolates, displayed exactly the same
sas profile. The sas genes were also identical for
nine of 13 isolates belonging to CC5, including
sporadic and PFGE C3-ST5 and D8-ST228 epi-
demic isolates. By contrast, the two ST22 (PFGE
L1) isolates differed by two alleles (sasB and sasD).
To investigate the putative evolutionary rela-
tionships between sporadic and epidemic isolates
within CC5 and CC8, an MP tree was constructed
for each of them on the basis of the concatenated
sequences of the 14 (sas+hk) genes. Then, SCCmec
and spa types were included, assuming the fewest
additional changes to the trees [17] (Fig. 2).
Within CC5 (Fig. 2a), the following evolution-
ary scenarios are proposed: ST5 was associated
with four cassette types, implying that MRSA
isolates of this ST must have arisen by at least four
distinct acquisitions of the SCCmec element. We
propose that the insertion of SCCmec type IV and
SCCmec type II into the common ST5-spa t002
MSSA ancestor strain were the events responsible
for the founding of the C3 and G10 epidemic
MRSA clones, respectively. Insertion of SCCmec
type I into an ST5 MSSA strain led to the ST5-
MRSA-I and then the ST228-MRSA-I MRSA line-
age from which the D8-ST228-MRSA-I MRSA
epidemic clone finally evolved, as supported by
the existence of intermediate evolutionary steps
represented by ST5-MRSA-I-spa t001 and ST228-
MRSA-I-spa t001 sporadic isolates. One sporadic
isolate was identical to the D8 epidemic strain by
all genetic markers except PFGE. Similarly, the
epidemic C1 strain is a likely descendant from the
G10 lineage by two point mutations (of sasB and
tpi). Finally, the insertion of SCCmec type III into
an ST5 MSSA isolate led to a sporadic strain that
further differs from the C3 and G10 strains by two
spa repeats and a point mutation in the sasD gene.
Within CC8, three types of SCCmec were found
(Fig. 2b). The A1-ST247-MRSA-I strains evolved
from a putative ST250 MSSA ancestor as indi-
rectly suggested by the existence of an ST250-
MRSA-IV sporadic strain. This ST250 MSSA strain
itself appears to be derived from a putative ST8
MSSA ancestor, common to all strains belonging
to CC8. The insertion of SCCmec type IV into this
common ST8 MSSA ancestor is probably at the
origin of the ST8-MRSA-IV A20 strains, from
which A21 strains presumably derived. As ob-
served for ST5, the insertion of SCCmec type III
into an ST8 MSSA strain founded a sporadic
MRSA isolate that, besides the SCCmec type,
differs from the putative ST8 MSSA ancestor by
a spa repeat and a point mutation in the sasD gene.
Interestingly, all other sporadic isolates belonging
to CC8 appear to represent ‘dead-end’ descen-
dants of epidemic strains.
agr type distribution
The agr group 1, shown by strains belonging to
CC8, CC45 and ST377, was the most frequent agr
group among both sporadic and epidemic isolates
(50% and 70% respectively) (Table 1). Group 2
was shown by 43% of sporadic isolates and 30% of
epidemic isolates, all belonging to CC5. Group 3
was found only in one ST30 sporadic isolate.
Toxin gene distribution
All but four isolates were negative for TSST, PVL,
exfoliatin A and exfoliatin B genes (Table 1).
The two G10-ST5-MRSA-I epidemic isolates
harboured the tst gene, and two sporadic isolates
(ST30 and ST377) were PVL-positive.
Antibiotic susceptibility profiles and resistance
gene distribution
Both the sporadic and epidemic isolate groups
were heterogeneous regarding their profiles of
Fig. 3. Doubling time of epidemic (n = 16) and sporadic
(n = 16) isolates. The diamonds indicate the mean of each
group and the 95% CI around the mean. The notched lines
indicate the corresponding percentile range.
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resistance to non-b-lactam drugs (Table 1), with a
range of non-susceptibility to one to eight drugs
for both sporadic and epidemic isolates. There
were few differences between sporadic and epi-
demic isolates belonging to the same clonal type
(Table 1). One ST247 sporadic isolate was
rifampin-resistant (as was one of three isolates
of A1-ST247-MRSA-I epidemic clone). The ST887-
MRSA-IV sporadic isolate (single-locus variant of
ST45) presented an ‘additional’ resistance to
erythromycin (ermC) as compared to the three
of four B2-ST45-MRSA-IV isolates. An ST231-
MRSA-II sporadic isolate (single-locus variant of
ST5) was tetracycline-susceptible (lacking the tetK
gene) as compared to G10-ST5-MRSA-II epidemic
isolates. However, similar single drug resistance
variation was also observed between resistance
profiles of isolates belonging to the same PFGE
epidemic type (Table 1).
Growth rates
The doubling time in the exponential phase of
growth was evaluated for 16 epidemic isolates
(two of each PFGE epidemic type, except for types
D8 and C1, each represented by a single isolate)
and all sporadic isolates (n = 16). Sporadic iso-
lates showed marginally shorter doubling times
than epidemic isolates, with mean doubling times
±2 standard errors of the mean of 39 ± 2 and
43 ± 3 min, respectively (p 0.04), (Fig. 3).
There were no differences in growth rate
related to PFGE group or type, spa type, MLST
CC or ST. Similarly, there was no significant
difference in growth rates related to SCCmec type
or to the number of resistance genes harboured by
the isolates tested. Remarkably, the strains with
TSST or PVL (n = 4) had a doubling time of
35 ± 2 min, as compared to 42 ± 2 min for the
PVL- and TSST-negative strains. However, the
sample size was too small to allow any conclu-
sions to be drawn.
DISCUSSION
Understanding the mechanisms implicated in the
spreading capacities of MRSA is a major and still
unmet challenge. The epidemiological success of
epidemic MRSA clones is likely to be due to the
conjunction of extrinsic (environmental and host-
associated) factors and intrinsic (genetic) deter-
minants of the bacterium itself, such as the ability
to colonize or invade the host [6]. These determi-
nants are still unknown. However, the current
understanding is that a few particularly well-
adapted MRSA lineages (initially defined by
common PFGE patterns) were able to spread
worldwide, suggesting that these genetic deter-
minants lay in the genetic background of these
MRSA clones [2]. In the present study, we
compared the genetic backgrounds of 36 MRSA
isolates presenting ‘epidemic’ or ‘sporadic’ PFGE
profiles and collected under a ‘common’ environ-
mental pressure (Belgian hospitals) during a
common period of time (11 years). The objective
was to identify possible intrinsic determinants
implicated in their epidemiological behaviour.
Seven hk genes (MLST) plus eight genes encoding
proteins expressed on the bacterial surface in
direct interaction with the host were explored by
partial sequencing, whereas genetic determinants
of four toxin and nine acquired drug mechanisms
were examined by PCR.
We selected ‘sporadic’ and ‘epidemic’ isolates
on the basis of the frequency of occurrence of
PFGE profile in the hospital population. This
strategy was guided by two main factors: (i) PFGE
is the reference standard method used by the
Belgian Reference Laboratory for national hospi-
tal surveys of MRSA since 1992 [27]; and (ii) the
PFGE pattern is a restriction map of genomic
DNA, and thus possibly reflects genetic events
across the chromosome of the isolates tested that
may be involved in their epidemic behaviour [28].
The study of pandemic clones with a ‘long’
evolutionary history has shown that adaptation
of the same clone in many different ecosystems
can lead to the appearance of multiple PFGE
profiles [4]. Selection based on PFGE profiles was
therefore at risk of selecting as ‘sporadic strains’
sub-clonal variants of epidemic strains presenting
‘drifted’ restriction patterns. However, the eco-
system is supposed to be ‘common’ to all isolates
selected here. Furthermore, our working defini-
tion of sporadic isolates was those presenting
more than six fragment differences from any
other PFGE pattern in our database, which theo-
retically represents a distance of at least three
genetic events from any other isolates [11]. How-
ever, some of the sporadic MRSA isolates identi-
fied here could still be the result of the
importation of strains that are epidemic in their
region of origin. In the same way, the possibility
that one of the sporadic MRSA isolates identified
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here could emerge in the future as an epidemic
clone cannot be ruled out.
On the basis of MLST, the majority (53%) of
MRSA sporadic isolates belonged to the same
four MLST STs as seven of the nine epidemic
MRSA clones. Furthermore, all but one belonged
to four of the five major CCs of MRSA pandemic
clones (CC8, CC5, CC45 and CC30). This degree
of relatedness is consistent with findings from
previous studies of MRSA strains ‘of rare occur-
rence’ [5,6].
However, when MLST and SCCmec types were
combined, only four of 17 clonal types identified
in the present study were common to both
sporadic and epidemic isolates. MP trees based
on sas genes, which encode proteins expressed on
the bacterial surface and are supposed to interact
with the host, classified all isolates in similar
groups or CCs as hk genes, with no striking
difference between the ‘sas profiles’ of epidemic
and sporadic isolates belonging to the same CC,
which is consistent with other reports [17,29].
The combination of sequence-based genotypic
markers, including sequences of 14 fragments of
hk and sas genes, spa typing and SCCmec typing,
allowed us to explore the evolutionary relation-
ships between sporadic and epidemic MRSA
isolates in detail. Our results indicate that spo-
radic isolates could be classified in four main
‘evolutionary groups’. The first group was com-
posed of two sporadic isolates (ST377 and ST30)
that were phylogenetically distant from epidemic
isolates. These two isolates possessed several
characteristics usually attributed to CA-MRSA:
SCCmec type IV or V, production of PVL toxin,
limited antibiotic resistance profile, and a higher
in vitro growth rate [30]. Considering these sim-
ilarities with CA-MRSA, we compared the PFGE
profiles of these two sporadic isolates with the
PFGE profiles of representative Belgian PVL-
positive CA-MRSA strains. As expected, the
ST30 sporadic isolate clustered in the same group
(group J) as several ST30 and ST36 CA-MRSA
isolates recently reported in Belgium (<7 fragment
differences) [24]. This was confirmed by closely
related or identical spa types between this spo-
radic HA-MRSA isolate and these CA-MRSA
isolates. Although we found no similarity be-
tween the ST377 sporadic HA-MRSA isolate and
Belgian CA-MRSA isolates in our collection by
PFGE or spa typing, ST377 CA-MRSA clones have
been reported in several parts of the world [31].
Aires de Souza and De Lencastre also observed
strong similarities between sporadic HA-MRSA
and CA-MRSA isolates, and proposed that some
MRSA clones described as community-acquired
may actually originate from those healthcare-
associated sporadic isolates [5]. This scenario is
particularly plausible regarding the ST30 PVL-
positive sporadic isolate, since almost 20% of
MSSA isolates from patients admitted to Belgian
hospitals belong to CC30 and occasionally carry
the PVL-encoding genes [32]. However, the
‘opposite’ theory is in this case an alternative
explanation. This MRSA clone could have origi-
nated in the community, and then have moved to
the hospital setting, but remained sporadic being
not sufficiently adapted to the hospital setting.
The second group of sporadic isolates pre-
sented the same genetic background as epidemic
isolates but possessed a distinct type of SCCmec,
as illustrated by the ST8-MRSA-III and ST5-
MRSA-III sporadic isolates. Since these isolates
belong to the same lineage as very successful
clones, their failure to spread may be partially
explained by the type of SCCmec that these
isolates carry. The size and the fitness cost due
to additional genes carried have been proposed as
explanations for the differences in the frequency
of acquisition and stability of different types of
SCCmec [17,33]. Indeed, SCCmec type III is a large
cassette (67 kb), containing several additional
drug resistance genes [34], as compared to ‘slim-
mer’ SCCmec types carried by epidemic strains in
those CCs. However, our results do not confirm
differences in fitness by type or size of the SCCmec
element.
Isolates in the third and largest group (n = 8)
were either phylogenetically identical or single-
step descendants of epidemic strains. Some of
these isolates could be ‘misclassified’ epidemic
isolates presenting ‘drifted PFGE patterns’, as
discussed above. However, as compared to the
epidemic isolates sharing the same genetic back-
ground, several of these isolates showed differ-
ences in their resistance gene content. Resistance
genes are known to be located on mobile genetic
elements (MGEs), together with other genes of
potential epidemiological and ecological rele-
vance. For example, the tetK gene (which was
lacking in the ST231-MRSA-II sporadic strain as
compared to its closely related G10-ST5-MRSA-II
epidemic isolates) has been found to be located on
the same plasmid (pMS62) as the qacA ⁄B gene
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cluster, which confers resistance to the quaternary
ammonium compounds frequently used in hos-
pitals as disinfectants [35]. The same rationale
could apply for less widespread ‘minor epidemic’
clones, as compared to the more successful
epidemic clones that they seem to descend from.
For example, the ‘less diffused’ C1-ST225-MRSA-
II clone lacks the tetM and the tst genes as
compared to strains belonging to the ‘major
epidemic’ G10-ST5-MRSA-II clone.
The last ‘evolutionary group’ contained spo-
radic isolates that were also closely related to
epidemic isolates but, instead of descending from
these, they rather reflect ‘intermediate’ steps
between epidemic strains and their putative
ancestor. For example, the two ST5-MRSA-I spo-
radic isolates represent a transition stage between
an ST5 MSSA ancestor and the D8-ST228-MRSA-I
‘Southern German’ epidemic clone. The presence
of such strains in the national Belgian collection
constitutes an argument in favour of local emer-
gence as a plausible explanation for the origin of
this recent epidemic clone, considering that ST5
MSSA isolates are endemic among patients in
Belgian hospitals [32].
Growth rate is one of the determinants of
bacterial ‘fitness’, together with the ability to
survive in the inanimate environment and to
colonise or invade hosts, as well as the anti-
biotic resistance profile [6]. In this study, spo-
radic isolates did not show an impaired
generation time as compared to epidemic
strains. On the contrary, the mean doubling
time of the sporadic isolates group was slightly
shorter than the mean doubling time of epi-
demic isolates. Given the small size and the
heterogeneity of the sample tested, these results
should be interpreted with caution. Neverthe-
less, reduced growth capacities are unlikely to
explain the ‘impaired’ epidemiological success
of these sporadic isolates. We found no associ-
ation between the growth rate of the isolates
tested and either their resistance gene content
(including SCCmec type) or genetic background.
By contrast, the few isolates harbouring lukS–
lukF or tst examined here showed high growth
rates, although this ability cannot be attributed
to the toxin gene itself. Toxin genes are located
on MGEs, as are resistance genes.
International molecular epidemiological stud-
ies established that a limited set of epidemic
clones was responsible for a large majority of
MRSA infections worldwide [2]. These epidemic
clones share a common genetic background with
successful MSSA lineages, suggesting that the
genetic backgrounds confer a selective advantage
to S. aureus, regardless of the antibiotic resistance
profile [2,32]. In the present study, the majority of
sporadic MRSA isolates identified over an 11-year
period in national surveys in hospitals showed
genetic backgrounds that were very close to those
of epidemic isolates (either as descendants or as
ancestors), and no in vitro fitness loss. Half of
these sporadic isolates differed from related
epidemic isolates in their accessory genome (such
as methicillin resistance cassette type or resistance
gene content). The same type of discrepancies
were observed between ‘widely spread’ and
‘scattered’ epidemic clones belonging to common
lineages. These differences, together with diver-
gent PFGE patterns, probably reflect inser-
tion ⁄ deletion of MGEs that may be linked to
spreading capacities. Further characterization of
the accessory genome contents of both sporadic
and epidemic isolates could help identify the
genetic factors involved in modulating the trans-
mission capacity of MRSA strains.
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